Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX

BACKGROUND: The complete resection rate of pancreatic cancer has increased because of the advent of efficacious first-line treatments for unresectable pancreatic cancer. Still, strategies regarding adjuvant therapy after neoadjuvant FOLFIRINOX treatment remain to be established. METHODS: Data on 144...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jin Ho, Kim, Min Kyu, Lee, Sang Hyub, Park, Jin Woo, Park, Namyoung, Cho, In Rae, Ryu, Ji Kon, Kim, Yong-Tae, Jang, Jin-Young, Kwon, Wooil, Kim, Hongbeom, Paik, Woo Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549517/
https://www.ncbi.nlm.nih.gov/pubmed/36226066
http://dx.doi.org/10.3389/fonc.2022.945829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549517/
https://www.ncbi.nlm.nih.gov/pubmed/36226066
http://dx.doi.org/10.3389/fonc.2022.945829

Ejemplares similares